Datensatz

Sos,  Martin L.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Rode,  Haridas B.
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Heynck,  Stefanie
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Peifer,  Martin
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Fischer,  Florian
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Klüter,  Sabine
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Pawar,  Vijakumar G.
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Reuter,  Cecile
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Heuckmann,  Johannes M.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Weiss,  Jonathan
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Ruddigkeit,  Lars
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Rabiller,  Matthias
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Koker,  Mirjam
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Simard,  Jeffrey R.
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Getlik,  Matthäus
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Yuza,  Yuki
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Chen,  Tzu-Hsiu
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Greulich,  Heidi
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;

Thomas,  Roman K.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Rauh,  Daniel
1 Center of Integrated Oncology and Department I of Internal Medicine, University of Köln, Cologne, Germany; 2 Chemical Genomics Centre of the Max Planck Society, Dortmund, Germany; 3 Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan; 4 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 5 Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 6 The Broad Institute of MIT and Harvard, Cambridge, Massachusetts;